香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示不會就本公告全部或任何部份內容而產 生或因依賴該等內容而引致之任何損失承擔任何責任。 茲提述瀛晟科學有限公司（「本公司」，連同其附屬公司統稱「本集團」）日期為二零二五年 六月三十日的公告（「該公告」），內容有關更新本公司為改善本集團的流動資金及財務狀 況所採取的計劃及措施，以解決截至二零二四年十二月三十一日止年度之年報所載就持 續經營不發表意見（「不發表意見」），且該公告乃根據香港聯合交易所有限公司證券上市 規則（「上市規則」）第13.19條及證券及期貨條例（香港法例第571章）（「證券及期貨條例」）第 XIVA部項下的內幕消息條文（定義見上市規則）而作出。除文義另有所指外，本公告所用 詞彙與該公告所定義者具有相同涵義。 自該公告刊發起直至本公告日期，本公司已進一步實施以下計劃及措施，以改善本集團 的流動資金及財務狀況： (i) 於二零二五年九月十一日，本公司與配售代理訂立配售協議，按悉數包銷基準透過 配售代理配售30,951,496股本公司新股份（「配售事項」）。配售事項已於二零二五年九 ...

Core Viewpoint - Ying Sheng Science (00209) announced the resignation of Mr. Wang Xiaofeng as an executive director, effective from September 30, 2025, due to his need to devote more time to other affairs [1] Company Summary - Mr. Wang Xiaofeng's resignation is attributed to his requirement for additional time to manage other commitments [1]

智通财经APP讯，瀛晟科学(00209)发布公告，汪晓峰先生(汪先生) 因需要投入更多时间处理彼的其他事 务而辞任本公司执行董事，自2025年9月30日起生效。 ...

WINSHINE SCIENCE COMPANY LIMITED 瀛 晟 科 學 有 限 公 司 * （於百慕達註冊成立之有限公司） (股份代號：209) 董事名單與其角色及職能 瀛晟科學有限公司董事會（「董事會」）之董事 (「董事」) 成員之最新資料載列如下。 董事會 執行董事 王敬渝女士（主席） 翁祖鈿先生（行政總裁） 姚震港先生 非執行董事 林少鵬先生 獨立非執行董事 王鈺梅女士 胡欣綺女士 黃天瑩女士 董事會設立三個委員會。下表提供各董事會成員在這些委員會中所擔任的職位。 | | 董 事 | | | | --- | --- | --- | --- | | 委員會 | 審核委員會 | 薪酬委員會 | 提名委員會 | | 董事 | | | | | 王敬渝女士 | – | – | – | | 翁祖鈿先生 | – | – | – | | 姚震港先生 | – | – | – | | 林少鵬先生 | – | – | M | | 王鈺梅女士 | M | M | M | | 胡欣綺女士 | C | M | – | | 黃天瑩女士 | M | C | C | 附註： C 有關董事委員會的主席 M 有關董事委員會的成員 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示不會就本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 WINSHINE SCIENCE COMPANY LIMITED 瀛 晟 科 學 有 限 公 司 * （於百慕達註冊成立之有限公司） (股份代號：209) 執行董事辭任 瀛晟科學有限公司（「本公司」）董事會（「董事會」）或（「董事」）謹此宣佈，汪曉峰先 生（「汪先生」）因需要投入更多時間處理彼之其他事務而辭任本公司執行董事，自二零 二五年九月三十日起生效。 汪先生已確認彼與董事會之間並無分歧，概無有關彼辭任之事宜須敦請本公司股東垂注。 董事會對汪先生於彼任內為本公司所作出之寶貴貢獻表示衷心感謝。 承董事會命 瀛晟科學有限公司 主席 王敬渝女士 香港，二零二五年九月三十日 於本公告日期，董事會由下列董事組成： 執行董事： 王敬渝女士（主席） 翁祖鈿先生（行政總裁） 姚震港先生 獨立非執行董事： 王鈺梅女士 胡欣綺女士 黃天瑩女士 非執行董事： 林少鵬先生 * 僅供識別 ...

WINSHINE SCIENCE COMPANY LIMITED 瀛晟科學有限公司* （於百慕達註冊成立的有限公司） （股份代號：209） 各位非登記股東1： 瀛晟科學有限公司(「本公司」) - 於本公司網站登載公司通訊之通知及更改公司通訊發佈模式 A. 於本公司網站登載公司通訊之通知 此通知 閣下，本公司之下述公司通訊2 (「本次公司通訊」)之英文及中文版本現已登載於本公司網站 www.winshine.com（「本公司網站」）及香港聯合交易所有限公司（「聯交所」）網站www.hkexnews.hk（「聯交所網 站」）以供閱覽： • 二零二五年中期報告 請於本公司網站「投資者關係」一欄或聯交所網站內讀取本次公司通訊。若閣下早前曾要求收取公司通訊的印刷本，本次公司通訊的 印刷本已隨函附上。 B. 更改公司通訊發佈模式 本公司採納透過電子方式向其非登記股東發佈日後公司通訊的新安排。請注意，所有日後公司通訊的英文及中文版本將在 本公司網站www.winshine.com和聯交所網站www.hkexnews.hk上提供（「網站版本」）。除非 閣下提出要求，公司不會向 閣下郵寄公司通訊的印刷本。 承董事會命 瀛晟科學 ...

WINSHINE SCIENCE COMPANY LIMITED 瀛晟科學有限公司* （於百慕達註冊成立的有限公司） （股份代號：209） 各位註冊股東： 於本公司網站登載公司通訊之通知 謹此通知 閣下，瀛晟科學有限公司（「本公司」）之下述公司通訊1（「本次公司通訊」）之英文及中文版本，現已登載於 本公司網站www.winshine.com（「本公司網站」）及香港聯合交易所有限公司（「聯交所」）網站www.hkexnews.hk（「聯 交所網站」）以供閱覽： • 二零二五年中期報告 請於本公司網站「投資者關係」一欄或聯交所網站內讀取本次公司通訊。若閣下早前曾要求收取公司通訊的印刷本，本次公 司通訊的印刷本已隨函附上。 為了支援通過電郵進行電子通訊，本公司建議 閣下向本公司香港股份過戶登記分處卓佳證券登記有限公司（「香港股份過 戶登記分處」）（地址為香港夏慤道16號遠東金融中心17樓）發出（不少於七天的）合理書面通知，或發送電郵至 is-ecom@vistra.com向本公司提供 閣下的電郵地址。 股東有責任提供有效的電郵地址。若本公司沒有股東的電郵地址或 閣下提供的電郵地址無效，本公司將透過郵寄方式向 閣下發 ...

[Abbreviations](index=3&type=section&id=Abbreviations) This section lists the key abbreviations used throughout the report - Key abbreviations used in the report include 'Board', 'Company', 'Directors', 'Group', 'Listing Rules', 'China', 'SFO', 'Shares', 'Shareholders', 'Stock Exchange', 'HK$', 'RMB', 'US$', and '%'[5](index=5&type=chunk) [Corporate Information](index=4&type=section&id=Corporate%20Information) This section provides an overview of the company's fundamental corporate details and governance structure [Board of Directors](index=4&type=section&id=BOARD%20OF%20DIRECTORS) The Board of Directors experienced multiple changes during the reporting period, including appointments and resignations of executive, non-executive, and independent non-executive directors, with Ms. Wang Jingyu appointed as Chairperson on September 3, 2025, and Mr. Jiang Qinghui resigning as Chairperson on the same day - Ms. Wang Jingyu was appointed Executive Director and Chairperson on **September 3, 2025**[7](index=7&type=chunk)[9](index=9&type=chunk) - Mr. Weng Zutian serves as the Chief Executive Officer[7](index=7&type=chunk)[9](index=9&type=chunk) - Mr. Jiang Qinghui and Mr. Li Zhonghai resigned as Executive Directors on **September 3, 2025**[7](index=7&type=chunk)[9](index=9&type=chunk) - Ms. Hu Xinqi and Ms. Huang Tianying were appointed Independent Non-executive Directors on **August 22, 2025**[7](index=7&type=chunk)[9](index=9&type=chunk) [Audit Committee](index=4&type=section&id=AUDIT%20COMMITTEE) The Audit Committee's membership changed during the reporting period, with Ms. Hu Xinqi appointed as Chairperson on August 22, 2025, while Mr. Guo Jianxiong and Mr. Chen Zhuohao ceased to be chairpersons on August 8, 2025, and February 28, 2025, respectively - Ms. Hu Xinqi was appointed Chairperson of the Audit Committee on **August 22, 2025**[8](index=8&type=chunk)[9](index=9&type=chunk) - Mr. Guo Jianxiong ceased to be Chairperson of the Audit Committee on **August 8, 2025**[8](index=8&type=chunk)[9](index=9&type=chunk) [Remuneration Committee](index=4&type=section&id=REMUNERATION%20COMMITTEE) The Remuneration Committee's membership changed during the reporting period, with Ms. Huang Tianying appointed as Chairperson on August 22, 2025, while Mr. Weng Zutian and Mr. Chen Zhuohao ceased to be chairpersons on August 22, 2025, and February 28, 2025, respectively - Ms. Huang Tianying was appointed Chairperson of the Remuneration Committee on **August 22, 2025**[8](index=8&type=chunk)[9](index=9&type=chunk) - Mr. Weng Zutian ceased to be Chairperson of the Remuneration Committee on **August 22, 2025**[8](index=8&type=chunk)[9](index=9&type=chunk) [Nomination Committee](index=5&type=section&id=NOMINATION%20COMMITTEE) The Nomination Committee's membership changed during the reporting period, with Ms. Huang Tianying re-designated as Chairperson on September 3, 2025, and Mr. Jiang Qinghui ceasing to be Chairperson on the same day - Ms. Huang Tianying was re-designated as Chairperson of the Nomination Committee on **September 3, 2025**[10](index=10&type=chunk)[11](index=11&type=chunk) - Mr. Jiang Qinghui ceased to be Chairperson of the Nomination Committee on **September 3, 2025**[10](index=10&type=chunk)[11](index=11&type=chunk) [Company Secretary](index=5&type=section&id=COMPANY%20SECRETARY) Ms. Yu Yayun was appointed Company Secretary on July 7, 2025, while Mr. Lin Guanhui resigned on the same day - Ms. Yu Yayun was appointed Company Secretary on **July 7, 2025**[10](index=10&type=chunk)[12](index=12&type=chunk) - Mr. Lin Guanhui resigned as Company Secretary on **July 7, 2025**[10](index=10&type=chunk)[12](index=12&type=chunk) [Other Corporate Information](index=5&type=section&id=Other%20Corporate%20Information) The Company's shares are listed on the Hong Kong Stock Exchange with stock code 209, its registered office is in Bermuda, and its principal place of business in Hong Kong is at Shun Tak Centre; key banks include HSBC, Bank of Communications Hong Kong Branch, and China Guangfa Bank Zhongshan Branch, with Tianjian International Certified Public Accountants Limited as auditor - Shares are listed on the Hong Kong Stock Exchange, stock code **209**[11](index=11&type=chunk)[12](index=12&type=chunk) - The registered office is located at Clarendon House, Bermuda[11](index=11&type=chunk)[12](index=12&type=chunk) - The principal place of business in Hong Kong is Unit 907B, 9th Floor, China Merchants Tower, Shun Tak Centre, 168–200 Connaught Road Central, Hong Kong[11](index=11&type=chunk)[12](index=12&type=chunk) - The auditor is Tianjian International Certified Public Accountants Limited[14](index=14&type=chunk)[15](index=15&type=chunk) [Management Discussion and Analysis](index=7&type=section&id=Management%20Discussion%20and%20Analysis) This section provides an overview of the Group's business operations, financial performance, and future outlook [Business Review](index=7&type=section&id=BUSINESS%20REVIEW) The Group primarily engages in toy manufacturing and trading, as well as agricultural product cultivation and sales; for the interim period ended June 30, 2025, the toy business continued to face challenges due to US tariffs and rising labor costs in China, leading to decreased order volume and increased gross loss, while the agricultural products business generated no revenue - The Group's principal businesses are **toy manufacturing and trading**, and **agricultural product cultivation and sales**[16](index=16&type=chunk)[21](index=21&type=chunk) - The toy business is affected by **US tariffs on China** and **rising minimum wage and social insurance costs in China**, leading to a continuous decline in order volume and pressure on profit margins[16](index=16&type=chunk)[17](index=17&type=chunk)[21](index=21&type=chunk) - For the interim period ended June 30, 2025, the agricultural product cultivation and sales business generated **no revenue** (2024: HK$1.3 million)[18](index=18&type=chunk)[21](index=21&type=chunk) Key Financial Performance (Six Months Ended June 30) | Metric | 2025 (HK$ Thousand) | 2024 (HK$ Thousand) | Change (HK$ Thousand) | Change Rate | Reference Chunk | | :--- | :--- | :--- | :--- | :--- | :--- | | Toy Segment Revenue | 148,400 | 189,800 | (41,400) | -21.8% | [20, 23] | | Agricultural Products Segment Revenue | 0 | 1,300 | (1,300) | -100% | [18, 21, 26, 32] | | Gross Loss/Profit | (10,000) | 4,100 | (14,100) | -343.9% | [18, 22] | | Loss for the Period | (38,300) | (26,700) | (11,600) | +43.4% | [19, 22] | [Financial Review](index=8&type=section&id=FINANCIAL%20REVIEW) The Group's financial position shows an increase in net current liabilities, a decrease in cash and cash equivalents, an expanded capital deficiency, and a higher gearing ratio; to improve its financial health, the Group has taken measures including extending bank financing maturity dates, implementing cost-saving initiatives, and exploring other financing arrangements, while foreign currency risk is considered not significant and certain assets are pledged for bank financing, with no material contingent liabilities currently [Liquidity, Financial Resources and Capital Structure](index=8&type=section&id=Liquidity,%20Financial%20Resources%20and%20Capital%20Structure) As of June 30, 2025, the Group's net current liabilities, total borrowings, and capital deficiency attributable to owners of the Company all increased, with a deterioration in the current ratio and gearing ratio; to address funding pressure, the Company completed a share subscription in January 2025, raising approximately HK$1.2 million in net proceeds for working capital Liquidity and Capital Structure Metrics | Metric | June 30, 2025 (HK$ Million) | December 31, 2024 (HK$ Million) | Change (HK$ Million) | Change Rate | Reference Chunk | | :--- | :--- | :--- | :--- | :--- | :--- | | Net Current Liabilities | 253.3 | 220.3 | 33.0 | +15.0% | [27, 33] | | Cash and Cash Equivalents | 34.1 | 55.3 | (21.2) | -38.3% | [27, 33] | | Current Ratio | 0.47 times | 0.54 times | (0.07) | -13.0% | [27, 33] | | Total Loans | 229.8 | 217.1 | 12.7 | +5.8% | [28, 33] | | Capital Deficiency Attributable to Owners of the Company | 173.8 | 139.0 | 34.8 | +25.0% | [29, 33] | | Gearing Ratio | 170% | 136.7% | 33.3% | +24.4% | [29, 33] |

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示不會就本公告全部或任何部份內容而產 生或因依賴該等內容而引致之任何損失承擔任何責任。 WINSHINE SCIENCE COMPANY LIMITED 209 二零二四年年報進一步補充公告 茲提述(i)瀛晟科學有限公司（「本公司」，連同其附屬公司統稱「本集團」）於二零二五年四 月三十日刊發的截至二零二四年十二月三十一日止年度之年度報告（「二零二四年年 報」）；及(ii)本公司日期為二零二五年八月二十二日內容有關二零二四年年報之補充公告 （「補充公告」）。除另有定義外，本公告所用詞彙與補充公告所界定者具有相同涵義。 董事會謹此進一步補充以下有關配售A及配售B所得款項用途及新購股權計劃的額外資 料。 新購股權計劃項下可供授出的購股權數目 由於新購股權計劃於二零二四年十一月十九日才獲採納，於二零二四年一月一日，計劃 授權限額及服務提供者分項限額下並無可供授出的購股權。於二零二四年十二月三十一 日，計劃授權限額下可供授出可認購14,535,748股股份的購股權及服務提供者分項限額下 可供授出可認購4 ...

[Supplementary Announcement Overview](index=1&type=section&id=%E8%A3%9C%E5%85%85%E5%85%AC%E5%91%8A%E6%A6%82%E8%BF%B0) This announcement supplements the 2024 annual report and prior announcements, providing additional details on Placing A and B proceeds and the new share option scheme - This announcement further supplements the 2024 annual report and previous supplementary announcements[4](index=4&type=chunk) - The supplementary content primarily concerns the use of proceeds from Placing A and Placing B and the new share option scheme[4](index=4&type=chunk) [Use of Proceeds](index=1&type=section&id=%E6%89%80%E5%BE%97%E6%AC%BE%E9%A0%85%E7%94%A8%E9%80%94) Net proceeds from Placing A and B were fully utilized for general working capital, consistent with previously disclosed purposes - The net proceeds from Placing A and Placing B have been fully utilized for the Group's **general working capital**[5](index=5&type=chunk) - The use of proceeds aligns with the purposes disclosed in the company's announcements on January 15, 2024, and August 26, 2024[5](index=5&type=chunk) [New Share Option Scheme](index=1&type=section&id=%E6%96%B0%E8%B3%BC%E8%82%A1%E6%AC%8A%E8%A8%88%E5%8A%83) The new share option scheme, adopted in November 2024, specifies the number of options available for grant and clarifies the revised maximum new shares to be issued - The new share option scheme was adopted on **November 19, 2024**[6](index=6&type=chunk) [Number of Share Options Available for Grant](index=1&type=section&id=%E6%96%B0%E8%B3%BC%E8%82%A1%E6%AC%8A%E8%A8%88%E5%8A%83%E9%A0%85%E4%B8%8B%E5%8F%AF%E4%BE%9B%E6%8E%88%E5%87%BA%E7%9A%84%E8%B3%BC%E8%82%A1%E6%AC%8A%E6%95%B8%E7%9B%AE) As of December 31, 2024, the number of share options available for grant under the new scheme is specified, with none available at year-start - As of January 1, 2024, no share options were available for grant under the scheme mandate limit or the service provider sub-limit[6](index=6&type=chunk) Number of Share Options Available for Grant under New Share Option Scheme as of December 31, 2024 | Item | Number of Share Options (shares) | | :--- | :--- | | Scheme Mandate Limit | 14,535,748 | | Service Provider Sub-limit | 4,360,724 | [Maximum Number of New Shares to be Issued](index=2&type=section&id=%E6%96%B0%E8%B3%BC%E8%82%A1%E6%AC%8A%E8%A8%88%E5%8A%83%E9%A0%85%E4%B8%8B%E5%B0%87%E4%BA%88%E7%99%BC%E8%A1%8C%E6%96%B0%E8%82%A1%E4%BB%BD%E7%9A%84%E6%95%B8%E7%9B%AE%E4%B8%8A%E9%99%90) The Board clarified and revised a clerical error regarding the maximum number of new shares to be issued under the new share option scheme - The Board clarified a clerical error in the supplementary announcement regarding the maximum number of new shares to be issued under the new share option scheme[8](index=8&type=chunk) Revision to Maximum Number of New Shares to be Issued under New Share Option Scheme | Metric | Before Revision | After Revision | | :--- | :--- | :--- | | Maximum New Shares | Not applicable (clerical error) | 14,535,748 shares | | Percentage of Existing Issued Share Capital | Approximately 10.0% | Approximately 9.4% | | Existing Issued Share Capital | 145,357,480 shares | 154,757,480 shares |